Cardiovascular Journal of Africa: Vol 30 No 2 (March/April 2019)

36 / 74

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019 102 AFRICA
49. Apostolova N, Gomez-Sucerquia LJ, Moran A, Alvarez A, Blas-Garcia
A, Esplugues JV. Enhanced oxidative stress and increased mitochondrial
mass during efavirenz-induced apoptosis in human hepatic cells. Br J
Pharmacol 2010; 160(8): 2069–2084.
50. Oyeyipo IP, Skosana BT, Everson FP, Strijdom H, Stefan S. Highly
active antiretroviral therapy alters sperm parameters and testicular anti-
oxidant status in diet-induced obese rats. Toxicol Res 2018; 34(1): 41–48.
51. Marnewick J, Rautenbach F, Venter I, Neethling H, Blackhurst DM,
Wolmarans P, Macharia M. Effects of rooibos (Aspalathus linearis ) on
oxidative stress and biochemical parameters in adults at risk for cardio-
vascular disease. J Ethnopharmacol 2011; 133(1): 46–52.
52. Standley L, Winterton P, Marnewick JL, Gelderblom WCA, Joubert E,
Britz TJ. Influence of processing stages on antimutagenic and antioxi-
dant potentials of rooibos tea. J Agric Food Chem 2001; 49(1): 114–117.
53. Kucharska J, Ulicna O, Gvozdjáková A, Sumbalová Z, Vancová O,
Bozek P, et al. Regeneration of coenzyme Q9 redox state and inhibition
of oxidative stress by rooibos tea (Aspalathus linearis) administration in
carbon tetrachloride liver. Physiol Res 2004; 53(5): 515–521.
54. Ajuwon O, Katengua-Thamahane E, van Rooyen J, Oguntibeju OO,
Marnewick JL. Protective effects of rooibos (Aspalathus linearis)
and/or red palm oil (Elaeis guineensis) supplementation on tert-butyl
hydroperoxide-induced oxidative hepatotoxicity in Wistar rats. Evid
Based Complement Alternat Med 2013; 2013: 984273.
55. Awoniyi DO, Aboua YG, Marnewick J, Brooks N. The effects of rooi-
bos (Aspalathus linearis), green tea (Camelli sinensis) and commercial
rooibos and green tea supplements on epididymal sperm in oxidative
stress-induced rats. Phyther Res 2012; 26(8): 1231–1239.
56. Kristoffersen U, Wiinberg N, Petersen CL, Gerstoft J, Gutte H, Lebech
AM, et al. Reduction in coronary and peripheral vasomotor function
in patients with HIV after initiation of antiretroviral therapy: a longi-
tudinal study with positron emission tomography and flow-mediated
dilation. Nucl Med Commun 2010; 31(10): 874–880.
57. Bertrand L, Dygert L, Toborek M.Antiretroviral treatment with
efavirenz disrupts the blood–brain barrier integrity and increases stroke
severity. Sci Rep 2016; 6: 39738.
58. Bergin H, Faltz M, Patel A, Pilavachi E, Amiri A, Gard P, et al. Anti-
retroviral drugs rilpivirine and efavirenz cause cardiovascular dysfunc-
tion: role of endoplasmic reticulum stress. HIV Med 2013 14: 26-26.
59. Weiß M, Kost B, Renner-Müller I, Wolf E, Mylonas I, Brüning A.
Efavirenz causes oxidative stress, endoplasmic reticulum stress, and
autophagy in endothelial cells. Cardiovasc Toxicol 2016; 16(1): 90–99.
60. De Gaetano DK, Rabagliati R, Tumbarello M, Tacconelli E, Amore C,
Cauda R, et al. Increased soluble markers of endothelial dysfunction in
HIV-positive patients under highly active antiretroviral therapy. AIDS
2003; 17(5): 765–768.
61. Wolf K, Tsakiris D, Weber R, Erb P, Battegay M; Swiss HIV cohort
study. Antiretroviral therapy reduces markers of endothelial and coagu-
lation activation in patients infected with human immunodeficiency
virus type 1. J Infect Dis 2002; 185(4): 456–462.
62. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP,
et al; ACTG 5152s study team. Endothelial function in human immu-
nodeficiency virus-infected antiretroviral-naive subjects before and after
starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials
Group) study 5152s. J Am Coll Cardiol 2008; 52(7): 569–576.
63. Bauer JA, Baliga RS, Liu C, Hoyt DG, Chaves AA, Bauer JA.
Saquinavir-induced endothelial toxicity vascular endothelial toxic-
ity induced by HIV protease inhibitor. Cardiovasc Toxicol 2004; 4(2):
199–206.
64. Shankar S, Dubé M, Gorski J, Klaunig JE, Steinberg HO. Indinavir
impairs endothelial function in healthy HIV-negative men. Am Heart J
2005; 150(5): 933.
65. Hsue P, Hunt P, Wu Y, Schnell A, Ho JE, Hatano H, et al. Association
of abacavir and impaired endothelial function in treated and suppressed
HIV-infected patients. AIDS 2009; 23(15): 2021–2027.
66. Jiang B, Hebert VY, Zavecz JH, Dugas TR. Antiretrovirals induce direct
endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 2006;
42(4): 391–395.
67. Demejia E, Puangpraphant S, Eckhoff R. Tea and inflammation. Tea in
Health and Disease Prevention. Elsevier Inc, 2013: 563–579.
68. Matsuda K, Nishimura Y, Kurata N, Iwase M, Yasuhara H. Effects of
continuous ingestion of herbal teas on intestinal CYP3A in the rat. J
Pharmacol Sci 2007; 103(2): 214–221.
69. M Nakano. Anti-viral agent prepared by basic and acidic extraction
of mangraves. Google Patents, Patent 5 929,047, 1999. Available from: